In the work of Sutrisno et al. (2018), it was proposed that genistein (1.04 and 1.3 mg/day) significantly reduced the expression of TNF-α and IL-6 in mice model of endometriosis (p < 0.05), which was comparable with the positive control, leuprolide acetate (0.00975 mg/5 days) (Sutrisno et al., 2018). The gene discussed is TNF; the disease is endometriosis.